Climate Change Data

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• Not disclosed

Social Achievements

• Not disclosed

Governance Achievements

• Approved a corporate governance manual on 01/03/1444H (corresponding to 27/09/2022G)

Climate Goals & Targets

Environmental Challenges

• Risks relating to the Company’s supply chain
• Risks related to concentration of sales among a limited number of distributors
• Risks related to the impact of increasing costs and operating expenses on the Company’s business
• Risks associated with permits, licenses and approvals necessary for the Company’s business
• Risks related to the regulatory requirements imposed by the SFDA and other regulators
• Risks related to quality, adverse publicity or product recalls affecting the Company’s products
• Risks related to product liability claims
• Risks related to the failure of customers and other independent third parties to accept the Company’s products
• Risks related to the uncertainties associated with research and development for new pharmaceutical products
• Risks related to the complexity of manufacturing the Company’s products
• Operational risks and unexpected interruptions to the Company’s business
• Risks related to cross border sales of products in foreign countries
• Risks related to Government restrictions on pricing
• Risks related to patent infringement actions
• Risks related to protecting certain trademarks on which the Company relies
• Risks related to maintaining the reputation of the “Jamjoom Pharma” brand
• Risks related to the Company’s Related Party Transactions
• Risks related to the outbreak of infectious diseases or other serious public health concerns, including the continuing global spread of COVID-19
• Risks related to the Company’s reliance on its senior Management and key personnel
• Risks related to the Company’s implementation of a newly adopted corporate governance manual
• Risks related to Management’s lack of experience in managing a publicly listed company
• Risks related to the adequacy of insurance coverage
• Risks related to interruptions in the Company’s information systems
• Risks related to litigation involving the Company
• Risks related to Zakat
• Risks related to the potential misconduct of its third-party agents outside the Kingdom
• Risks related to the Company’s current financing arrangements
• Risks related to Bank Guarantees provided on the Company’s behalf by the Shareholders
• Risks related to the Company’s Land Title
• Risks related to the Conversion of the loan extended to the Company’s Egyptian Subsidiary into a subordinated instrument
• The impact of political and economic risks on the Company’s operations
• Risks related to the increasing competition in the industry which the Company operates
• Financial risks related to the fluctuation of currency exchange rates
• Risk related to the Competition Law
• Risks related to changes in laws and government policies in the Company’s key markets
• Risks related to Saudization, non-Saudi employees, and other Labor Law requirements
• Risks related to changes in import and export laws and regulations
• Risks related to the imposition of additional fees or new taxes
• Risks related to changes in the calculation of Zakat and income tax
• Risks related to VAT

Mitigation Strategies

• Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: IFRS-KSA

Certifications: Null

Third-party Assurance: KPMG

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed